Analyst - EMS HCP Contract to Pay - Iberian Hub at Eli Lilly and Company

Cork, County Cork, Ireland

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Ability to establish and maintain internal strategic partnerships with compliance, finance, and other functions
Expertise in Contracting to Pay processes for assigned country (Iberian Hub)
Proficiency in monitoring daily operational dashboards to ensure compliance with SLAs
Knowledge of Anti-Corruption requirements for interacting with HCPs
Understanding of data capture requirements for Lilly’s ToV Disclosure, including data correction and reporting

Responsibilities

Provide excellent contracting and payment support to external Healthcare Professionals (HCPs) and internal affiliate business partners
Serve as a “go-to” information resource for Contracting to Pay queries from external HCPs and internal business partners
Deliver excellent customer experience through timely coordination and execution of HCP contract to pay processes for assigned country
Monitor daily operational dashboard to ensure compliance with pre-defined SLAs and ensure effective distribution across the team
Ensure adherence to Anti-Corruption requirements when interacting with and engaging HCPs
Ensure compliance with data capture requirements to support Lilly’s ToV Disclosure, including supporting data correction and reporting

Skills

Finance

Contract Management

Procurement

Analysis

SAP

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free